YOLFTbeta
60

Shandong Buchang Pharmaceuticals Co Ltd

603858 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

14.65CNY-0.24 (-1.61%)

Price History

Full chart

Market Stats

Previous Close14.89
Open14.84
Day Range14.63 – 14.89
52-Week Range14.01 – 18.47
Volume3.87M
Market Cap15.44B
P/E (TTM)63.65
Forward P/E0.00
EPS0.23
Dividend Yield3.89%
Beta0.29
50-Day Avg15.27
200-Day Avg15.98

About

Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicines in China and internationally. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Chao Zhao
  • Employees7.24K
  • HeadquartersNo. 369 Zhonghua West Road, Heze, China, 274000, China
  • Websitehttps://www.buchang.com

Leadership

  • Mr. Chao ZhaoPresident · b. 1967
  • Mr. Yi Min WangExecutive VP & Vice Chairman · b. 1961
  • Mr. Xiaogang ZhaoChief Financial Officer · b. 1979
  • Mr. Ren Hui XueVP of Marketing & Director · b. 1968
  • Ms. Xin WangDirector & Secretary · b. 1979
  • Dr. Zhao Buchang M.D.Founder
  • Kai ChengAccounting Supervisor
  • Mr. Wei Jun LiVice President of Administration & Human Resources · b. 1963
  • Haiqin WuChairman of the Academic Committee
  • Ms. Wei ZhaoVice President of Procument

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.87B7.04B8.59B10.33B11.66B12.32B13.86B13.66B14.26B16.01B15.76B14.95B13.25B11.01B11.88B
Growth (%)-+19.84%+22.10%+20.27%+12.79%+5.71%+12.52%-1.44%+4.32%+12.28%-1.52%-5.15%-11.41%-16.91%+7.90%
Cost of Revenue1.75B1.33B1.61B2.02B2.01B2.08B2.45B2.35B2.39B3.74B4.13B4.27B4.32B4.55B4.40B
Gross Profit4.12B5.70B6.98B8.31B9.65B10.24B11.41B11.31B11.87B12.27B11.63B10.68B8.92B6.45B7.48B
Gross Margin70.22%81.05%81.28%80.41%82.79%83.15%82.33%82.79%83.25%76.64%73.77%71.45%67.38%58.64%62.95%
Operating Expense2.73B4.21B5.55B6.75B5.91B8.27B9.66B9.04B9.44B9.90B9.88B11.93B8.49B6.70B6.00B
Operating Income1.39B1.49B1.43B1.56B3.74B1.97B1.76B2.27B2.43B2.37B1.75B-1.25B436.02M-246.75M1.48B
Operating Margin23.73%21.20%16.69%15.08%32.12%16.01%12.68%16.61%17.04%14.78%11.09%-8.36%3.29%-2.24%12.43%
EBITDA1.41B1.51B1.49B1.68B2.33B2.30B2.02B2.19B2.66B2.71B2.23B2.26B1.61B1.12B1.17B
EBITDA Margin24.08%21.52%17.37%16.30%19.97%18.68%14.55%16.06%18.67%16.94%14.17%15.09%12.17%10.13%9.83%
Net Income1.23B1.25B1.17B1.32B3.54B1.77B1.64B1.89B1.95B1.86B1.29B-1.53B318.97M-553.80M360.78M
Net Income Margin20.92%17.78%13.60%12.81%30.34%14.36%11.81%13.82%13.65%11.63%8.18%-10.23%2.41%-5.03%3.04%
R&D--165.76M232.47M358.30M458.92M489.37M480.24M505.36M533.42M408.60M284.12M335.08M486.02M240.10M
R&D as % of Total Revenue--1.93%2.25%3.07%3.72%3.53%3.51%3.55%3.33%2.59%1.90%2.53%4.42%2.02%
Interest Expense13.19M031.57M94.30M135.84M158.71M80.05M91.62M136.78M145.05M167.29M142.11M109.93M135.68M118.70M
Interest Expense % of Total Revenue0.22%0.00%0.37%0.91%1.17%1.29%0.58%0.67%0.96%0.91%1.06%0.95%0.83%1.23%1.00%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.44B5.67B6.94B9.10B15.76B18.67B19.20B20.03B21.19B22.89B23.99B21.95B20.89B19.33B19.24B
Total Liabilities1.64B1.65B2.66B4.65B8.50B5.96B5.98B6.17B7.40B9.08B9.54B9.68B9.52B9.52B9.81B
Total Equity2.63B3.81B4.10B4.40B7.15B12.61B13.14B13.73B13.64B13.71B14.42B12.36B11.62B10.22B10.01B
Cash1.49B1.49B1.22B2.08B1.85B3.81B2.17B1.69B1.83B1.47B1.22B2.15B694.13M818.81M1.22B
Total Debt308.70M210.00M870.00M1.65B1.96B6.00M1.80B2.25B2.72B3.45B3.54B3.15B2.35B2.47B-
Net Debt-1.18B-1.28B-348.97M-433.07M110.66M-3.80B-365.11M557.75M889.01M1.99B2.32B1.00B1.66B1.66B1.27B

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.55B1.35B1.11B1.78B2.12B1.67B1.96B2.05B2.62B1.96B1.32B2.76B-164.26M939.95M1.16B
Investing Cash Flow-561.22M-753.86M-984.34M-407.82M-2.53B-1.19B-4.31B-1.60B-1.27B-421.72M-655.67M-1.01B-195.06M-249.55M-
Financing Cash Flow-114.30M-602.33M-399.11M-510.56M176.09M1.58B616.51M-938.98M-1.23B-1.89B-770.88M-987.57M-1.07B-565.21M-
Capital Expenditure378.91M543.34M510.85M204.88M480.78M677.87M1.46B1.31B662.11M536.44M433.53M543.17M529.92M197.00M123.42M
Free Cash Flow1.17B805.84M603.11M1.58B1.64B990.91M506.93M741.00M1.96B1.42B886.98M2.21B-725.52M742.96M1.03B
Dividends Paid23.66M81.76M866.66M1.06B132.01M137.52M1.17B1.19B1.37B1.79B581.78M398.18M1.19B272.44M530.71M
FCF to OCF75.58%59.73%54.14%88.49%77.33%59.38%25.84%36.13%74.74%72.61%67.17%80.29%441.69%79.04%89.34%
Dividend Paid to FCF2.02%10.15%143.70%67.11%8.05%13.88%229.97%160.03%70.09%125.51%65.59%18.00%-164.61%36.67%51.31%

Earnings

Report DateMar 29, 2017Apr 26, 2017Aug 28, 2017Oct 26, 2017Dec 31, 2017Apr 28, 2018Jun 30, 2018Oct 26, 2018Dec 31, 2018Apr 26, 2019Aug 29, 2019Oct 26, 2019Dec 31, 2019Apr 28, 2020Aug 28, 2020Oct 27, 2020Dec 31, 2020Apr 28, 2021Aug 27, 2021Oct 27, 2021Dec 31, 2021Apr 27, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Apr 27, 2023
EPS Estimate--------------------------
EPS Actual0.440.190.400.390.440.180.430.450.580.250.470.500.540.280.540.450.420.370.490.300.010.010.350.41-2.640.41
Surprise--------------------------
TimingAfter-hoursPre-marketAfter-hoursAfter-hours-After-hours-After-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours--After-hoursPre-market-Pre-market---Pre-market

Key Statistics & Ratios

Market Cap15.44B
Enterprise Value17.96B
Trailing P/E63.65
Forward P/E0.00
Price / Sales1.38
Price / Book1.54
EPS0.23
Book Value9.69
Revenue (TTM)11.21B
Gross Profit (TTM)6.72B
EBITDA1.46B
Profit Margin2.10%
Operating Margin11.80%
Return on Equity0.65%
Return on Assets3.45%
Shares Outstanding1.05B
Shares Float378.21M
Beta0.29
Dividend Yield3.89%
Dividend Rate0.57
Payout Ratio171.88%

Dividends

20231×
0.96Aug 10, 2023
20221×
0.36Aug 16, 2022
20211×
0.53Aug 2, 2021
20201×
1.61Jul 20, 2020
20191×
1.61Aug 19, 2019
20181×
1.24Aug 17, 2018
20171×
0.96Jul 18, 2017

Stock Splits

  • Aug 19, 201913:10
  • Aug 17, 201813:10